Literature DB >> 23269810

Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors.

Nadine Althof1, J Lindsay Whitton.   

Abstract

Coxsackievirus B3 (CVB3) is known to infect stem cells in the neonatal central nervous system. Here, we evaluated the effects of CVB3 infection on the major source and repository of stem cells, the bone marrow (BM). Viral genome was detectable in BM within 24 h of infection, and productive infection of BM cells was evident, peaking at 48 h postinfection (p.i.), when ∼1 to 2% of BM cells produced infectious virus particles. Beginning at 2 to 3 days p.i., a dramatic and persistent loss of immature erythroid cells, B and T lymphocytes, and neutrophils was observed in BM and, by day 3 to 4 p.i., the femoral BM stroma was largely destroyed. Analysis of peripheral blood revealed a modest neutrophilia, a loss of reticulocytes, and a massive lymphopenia. The abundance of multipotent progenitor cells (Lin(-)/c-kit(+)/Flt3(+)) in BM declined ∼10-fold during CVB3 infection and, consistent with a deficiency of primitive hematopoietic progenitors, serum levels of the hematopoietic growth factor Flt3 ligand were dramatically elevated. Therefore, we analyzed the regenerative capacity of BM from CVB3-infected mice. Granulocyte/macrophage progenitors displayed a relatively normal proliferative ability, consistent with the fact that the peripheral blood level of neutrophils-which are very short-lived cells-remained high throughout infection. However, erythroid and lymphoid hematopoietic progenitors in BM from CVB3-infected mice showed a markedly reduced colony-forming capacity, consonant with the observed loss of both lymphocytes and immature erythroid cells/reticulocytes from the BM and peripheral blood. In summary, CVB3 infects the BM and exerts differential effects on the various hematopoietic progenitor populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23269810      PMCID: PMC3571374          DOI: 10.1128/JVI.03004-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  86 in total

Review 1.  Signal transduction via the stem cell factor receptor/c-Kit.

Authors:  L Rönnstrand
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

2.  Antiviral instruction of bone marrow leukocytes during respiratory viral infections.

Authors:  Tamar Hermesh; Bruno Moltedo; Thomas M Moran; Carolina B López
Journal:  Cell Host Microbe       Date:  2010-05-20       Impact factor: 21.023

3.  Post-hepatitic aplastic anaemia in children in Taiwan, a hepatitis prevalent area.

Authors:  D C Liang; K H Lin; D T Lin; C P Yang; K L Hung; K S Lin
Journal:  Br J Haematol       Date:  1990-04       Impact factor: 6.998

4.  Bone marrow failure with concurrent enteroviral infection in a newborn.

Authors:  A Tarcan; N Ozbek; B Gürakan
Journal:  Pediatr Infect Dis J       Date:  2001-07       Impact factor: 2.129

Review 5.  Myocarditis as systemic disease: new perspectives on pathogenesis.

Authors:  C M Carthy; D Yang; D R Anderson; J E Wilson; B M McManus
Journal:  Clin Exp Pharmacol Physiol       Date:  1997-12       Impact factor: 2.557

Review 6.  Bone marrow and the control of immunity.

Authors:  Ende Zhao; Huanbin Xu; Lin Wang; Ilona Kryczek; Ke Wu; Yu Hu; Guobin Wang; Weiping Zou
Journal:  Cell Mol Immunol       Date:  2011-10-24       Impact factor: 11.530

7.  Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.

Authors:  D Binder; J Fehr; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

8.  Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea.

Authors:  X T Yan; T M Tumpey; S L Kunkel; J E Oakes; R N Lausch
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-09       Impact factor: 4.799

9.  Involvement of interferon in virus-induced lymphopenia.

Authors:  A Schattner; A Meshorer; D Wallach
Journal:  Cell Immunol       Date:  1983-07-01       Impact factor: 4.868

10.  Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Daniel E Hassett; J Lindsay Whitton
Journal:  Med Microbiol Immunol       Date:  2003-08-19       Impact factor: 3.402

View more
  10 in total

1.  Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo.

Authors:  Teresa Rodríguez-Calvo; José-Manuel Rojas; Verónica Martín; Noemí Sevilla
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammation.

Authors:  Min Li; Kepeng Yan; Lin Wei; Yang Yang; Qian Qian; Wei Xu
Journal:  Med Microbiol Immunol       Date:  2017-10-17       Impact factor: 3.402

Review 3.  Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.

Authors:  Aaron Michels; Li Zhang; Anmar Khadra; Jake A Kushner; Maria J Redondo; Massimo Pietropaolo
Journal:  Pediatr Diabetes       Date:  2015-07-23       Impact factor: 4.866

4.  In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Authors:  Nadine Althof; Stephanie Harkins; Christopher C Kemball; Claudia T Flynn; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

5.  Type I IFN Signaling Is Dispensable during Secondary Viral Infection.

Authors:  Martin P Hosking; Claudia T Flynn; J Lindsay Whitton
Journal:  PLoS Pathog       Date:  2016-08-31       Impact factor: 6.823

6.  Differential susceptibility and response of primary human myeloid BDCA1(+) dendritic cells to infection with different Enteroviruses.

Authors:  Barbara M Schulte; Esther D Kers-Rebel; Amy C Prosser; Jochem M D Galama; Frank J M van Kuppeveld; Gosse J Adema
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

7.  Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers.

Authors:  Scott M Robinson; Ginger Tsueng; Jon Sin; Vrushali Mangale; Shahad Rahawi; Laura L McIntyre; Wesley Williams; Nelson Kha; Casey Cruz; Bryan M Hancock; David P Nguyen; M Richard Sayen; Brett J Hilton; Kelly S Doran; Anca M Segall; Roland Wolkowicz; Christopher T Cornell; J Lindsay Whitton; Roberta A Gottlieb; Ralph Feuer
Journal:  PLoS Pathog       Date:  2014-04-10       Impact factor: 6.823

8.  c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.

Authors:  Iwona A Buskiewicz; Andreas Koenig; Brian Roberts; Jennifer Russell; Cuixia Shi; Sun-Hwa Lee; Jae U Jung; Sally A Huber; Ralph C Budd
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

9.  The impact of juvenile coxsackievirus infection on cardiac progenitor cells and postnatal heart development.

Authors:  Jon Sin; Jenna M Puccini; Chengqun Huang; Mathias H Konstandin; Paul E Gilbert; Mark A Sussman; Roberta A Gottlieb; Ralph Feuer
Journal:  PLoS Pathog       Date:  2014-07-31       Impact factor: 6.823

Review 10.  Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output.

Authors:  Maria Fernanda Pascutti; Martje N Erkelens; Martijn A Nolte
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.